ursodeoxycholic acid has been researched along with Cystic Fibrosis in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.70) | 18.7374 |
1990's | 41 (55.41) | 18.2507 |
2000's | 9 (12.16) | 29.6817 |
2010's | 19 (25.68) | 24.3611 |
2020's | 3 (4.05) | 2.80 |
Authors | Studies |
---|---|
Karnsakul, W; Wasuwanich, P | 1 |
Staufer, K | 1 |
Alghisi, F; Alicandro, G; Asherova, I; Colombo, C; Corti, F; de Monestrol, I; Evans, H; Kashirskaya, N; Kondratyeva, E; Lewindon, PJ; Lindblad, A; Oliver, M; Ooi, CY; Padoan, R; Ramm, GA; Strandvik, B | 1 |
Bertolini, A; Bodewes, FAJA; Jonker, JW; van de Peppel, IP; Verkade, HJ | 1 |
Ashby, D; Cheng, K; Smyth, RL | 3 |
Bebawy, M; Chellappan, DK; de Jesus Andreoli Pinto, T; Dua, K; Gupta, G; Hansbro, PM | 1 |
Al Qatarneh, S; Lindblad, D; Michel, HK; Ozolek, J; Venkat, V; Weiner, DJ | 1 |
Boëlle, PY; Clement, A; Corvol, H; Debray, D; Guillot, L | 1 |
Heller, T; Kleiner, DE; Koh, C; Sakiani, S | 1 |
Bolan, C; Cortese, C; Harnois, D; Mallea, J | 1 |
Fisher, SE; Rabinowitz, SS; Schwarz, SM; Vo, HD; Xu, J | 1 |
Alonso, EM; Harned, R; Karmazyn, B; Krishnamurthy, R; Leung, DH; Ling, S; Magee, JC; Marshall, BC; Molleston, JP; Murray, KF; Narkewicz, MR; Palermo, J; Paranjape, SM; Romero, R; Schwarzenberg, SJ; Sherker, AH; Siegel, MJ; Weymann, A; Ye, W | 1 |
Drzymała-Czyż, S; Jończyk-Potoczna, K; Lisowska, A; Stajgis, M; Walkowiak, J | 1 |
Alicandro, G; Biffi, A; Colombo, C; Corti, F; Crosignani, A; Motta, V; Setchell, KDR; Zhang, W | 1 |
Narkewicz, MR | 1 |
Houwen, RH; van der Doef, HP; van der Ent, CK; van der Feen, C | 1 |
Boggia, B; Buonpensiero, P; De Gregorio, F; Di Pasqua, A; Ferri, P; Raia, V; Sepe, A; Siano, M | 1 |
Dockter, G; Herrmann, U; Lammert, F | 1 |
Bijvelds, MJ; Bodewes, FA; de Jonge, HR; Havinga, R; Verkade, HJ; Wouthuyzen-Bakker, M | 1 |
Espach, C; Glasmacher, C; Griese, M; Hartl, D; Hector, A; Kappler, M; Lang, T; Schweiger-Kabesch, A | 1 |
Hoskins, AC; Lewindon, PJ; O'Connell, NC; Pereira, TN; Ramm, GA; Setchell, KD; Shepherd, RW; Smith, JL | 1 |
Bailey, M; Clark, D; Desmond, CP; Roberts, SK; Wilson, J | 1 |
Alexander, GJ; Allison, ME; Bilton, D; Haworth, CS; Lomas, DJ; McKeon, D; Nash, KL | 1 |
Barbara, L; Colombo, C; Giunta, AM; Maspero, D; Piceni Sereni, L; Roda, A; Roda, E | 1 |
Bellamy, M; Geddes, D; Thomas, PS | 1 |
Stiehl, A | 2 |
Tanner, MS; Taylor, CJ | 1 |
Poupon, R; Poupon, RE | 2 |
Ghory, MJ; Hunter, GC; Rappaport, W; Shen, GK; Tsen, AC | 1 |
Angelico, M; Antonelli, M; Bertasi, S; De Santis, A; Diamanti, S; Goffredo, F; Martino, F; Merli, M; Quattrucci, S; Servi, R | 1 |
Lindblad, A; Strandvik, B | 1 |
van Berge-Henegouwen, GP; Van de Meeberg, PC; van Erpecum, KJ | 1 |
Luketic, VA; Sanyal, AJ | 1 |
Cirillo, NW; Zwas, FR | 1 |
Apostolo, MG; Bettinardi, N; Colombo, C; Crosignani, A; Giunta, A; Marzano, MT | 1 |
Anagnostopoulos, C; Feigelson, J; Munck, A; Navarro, J; Pecau, Y; Poquet, M | 1 |
Lacaille, F | 1 |
Bowler, IM; Irving, HC; Littlewood, JM; O'Connor, PJ; Robinson, PJ; Southern, KW | 1 |
Battezzati, PM; Bettinardi, N; Colombo, C; Giunta, A; Podda, M | 1 |
Burke, AF; Campbell, GR; FitzGerald, MX; Hegarty, JE; Maguire, OC; O'Brien, SM; Rowlands, BJ | 1 |
Champagne, J; Lacaille, F; Lenaerts, C; Lepage, G; Paradis, K; Rasquin-Weber, A; Ronco, N; Roy, CC; Sénéchal, L | 1 |
Bijleveld, CM; Heijerman, HG; Houwen, RH; Sinaasappel, M; van de Meeberg, PC; Vanberge-Henegouwen, GP | 1 |
Ashby, D; Cheng, K; Smyth, R | 2 |
Bishop, WP; McCray, PB; Scher, H | 1 |
Glaumann, H; Lindblad, A; Strandvik, B | 1 |
Battezzati, PM; Colombo, C; Podda, M; Strazzabosco, M | 1 |
Berenguer Lapuerta, J; Pérez-Aguilar, F | 1 |
Battezzati, PM; Castellani, MR; Colombo, C; Comi, S; Crosignani, A; Giunta, A; Melzi, ML | 1 |
Kowdley, KV | 1 |
Economou, H; Fotoulaki, M; Galli-Tsinopoulou, A; Nousia-Arvanitakis, S; Xefteri, M | 1 |
Beno, DW; Jiyamapa-Serna, VA; Kimura, RE; Lloyd-Still, JD; Uhing, MR | 1 |
Chapman, J; Hardcastle, J; Hardcastle, PT; Taylor, CJ | 1 |
Gatzen, M; Pausch, J | 1 |
Chazalette, JP; Figarella, C; Galabert, C; Lecuire, A; Lengrand, D; Montet, JC; Sotta, C | 1 |
Assaisso, M; Battezzati, PM; Colombo, C; Crosignani, A; Giunta, A; Podda, M; Setchell, KD; Zimmer-Nechemias, L | 1 |
Apostolo, MG; Assaisso, M; Bottani, P; Colombo, C; Roman, B | 1 |
Lerner, A; Rivlin, J | 1 |
Assaisso, ML; Balistreri, WF; Castellani, MR; Colombo, C; Giunta, A; Seregni, E | 1 |
Tanner, MS | 1 |
Chazalette, JP; Dimier, JL; Galabert, C; Lengrand, D; Montet, JC | 1 |
Montet, JC | 1 |
Borum, M; Fromm, H; Malet, PF | 1 |
Riely, CA | 1 |
Assaisso, M; Battezzati, PM; Colombo, C; Crosignani, A; Giunta, A; Ronchi, M | 1 |
Cotting, J; Lentze, MJ; Reichen, J | 1 |
Colombo, C; Nakagawa, M; Setchell, KD | 1 |
Colombo, C; Crosignani, A; Curcio, L; Giunta, A; Podda, M; Roda, A; Ronchi, M; Setchell, KD | 1 |
Bilton, D; Sahl, B; Webb, AK | 1 |
Howat, J; Salh, B; Webb, K | 1 |
29 review(s) available for ursodeoxycholic acid and Cystic Fibrosis
Article | Year |
---|---|
Cystic fibrosis-associated liver disease in children.
Topics: Adolescent; Adult; Age Factors; Alleles; alpha 1-Antitrypsin; Cause of Death; Child; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Esophageal and Gastric Varices; Female; Hepatomegaly; Homozygote; Humans; Hypertension, Portal; Liver; Male; Mutation; Prevalence; Primary Prevention; Sex Factors; Splenomegaly; Ursodeoxycholic Acid; Young Adult | 2020 |
Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Diseases; Ursodeoxycholic Acid | 2020 |
Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
Topics: Aftercare; Aminophenols; Aminopyridines; Benzodioxoles; Chloride Channel Agonists; Cholagogues and Choleretics; Cystic Fibrosis; Drug Combinations; Elasticity Imaging Techniques; Humans; Liver Diseases; Liver Transplantation; Quinolones; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Bile; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver; Liver Diseases; Nutritional Status; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
Hepatic Manifestations of Cystic Fibrosis.
Topics: Cholagogues and Choleretics; Cystic Fibrosis; Diagnosis, Differential; Humans; Hypertension, Portal; Liver Diseases; Liver Transplantation; Ursodeoxycholic Acid | 2019 |
Cystic Fibrosis-Associated Liver Disease in Lung Transplant Recipients.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Incidence; Liver Cirrhosis; Liver Transplantation; Lung Transplantation; Mutation; Postoperative Care; Quinolones; Survival Rate; Transplant Recipients; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
The liver in pediatric gastrointestinal disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Celiac Disease; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cystic Fibrosis; Humans; Infant; Inflammatory Bowel Diseases; Infliximab; Liver Diseases; Liver Function Tests; Mercaptopurine; Methotrexate; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2014 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Bile; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2014 |
Cystic fibrosis-associated liver disease.
Topics: Animals; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Portasystemic Shunt, Transjugular Intrahepatic; Ursodeoxycholic Acid | 2010 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2012 |
Liver disease in cystic fibrosis.
Topics: Adolescent; Adult; Bile Duct Diseases; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Susceptibility; Genetic Therapy; Humans; Liver Diseases; Membrane Proteins; Ursodeoxycholic Acid | 1995 |
Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children.
Topics: Adult; Bile Acids and Salts; Child; Cholestasis; Clinical Trials as Topic; Cystic Fibrosis; Female; Humans; Intestinal Absorption; Liver; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 1995 |
Cystic fibrosis. Is treatment with ursodeoxycholic acid of value?
Topics: Animals; Clinical Trials as Topic; Cystic Fibrosis; Gallbladder Diseases; Humans; Liver Diseases; Liver Function Tests; Ursodeoxycholic Acid | 1994 |
Therapy with ursodeoxycholic acid in cholestatic liver disease.
Topics: Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Postoperative Care; Pregnancy; Pregnancy Complications; Recurrence; Ursodeoxycholic Acid | 1993 |
The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
Topics: Alagille Syndrome; Biliary Atresia; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid in the treatment of chronic liver disease.
Topics: Chronic Disease; Clinical Trials as Topic; Cystic Fibrosis; Hepatitis, Chronic; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 1994 |
Oral bile acids in cystic fibrosis-associated liver disease.
Topics: Administration, Oral; Clinical Trials as Topic; Cystic Fibrosis; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Liver Diseases; Pilot Projects; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 1994 |
[Bile acids and their therapeutic use in children].
Topics: Adult; Animals; Bile Acids and Salts; Cell Membrane; Child; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Cystic Fibrosis; Humans; Immunosuppressive Agents; Ursodeoxycholic Acid | 1995 |
Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review.
Topics: Cholagogues and Choleretics; Cystic Fibrosis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid | 1997 |
Liver and biliary problems in cystic fibrosis.
Topics: Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diagnosis, Differential; Humans; Liver; Liver Diseases; Prognosis; Ursodeoxycholic Acid | 1998 |
[Hepatobiliary disease in cystic fibrosis].
Topics: Bile Duct Diseases; Biomarkers; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Diseases; Ursodeoxycholic Acid | 1998 |
Ursodeoxycholic acid therapy in hepatobiliary disease.
Topics: Biliary Tract Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2000 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Cholagogues and Choleretics; Cystic Fibrosis; Humans; Liver Diseases; Ursodeoxycholic Acid | 2000 |
[Treatment of cholestatic liver diseases].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Controlled Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Infant, Newborn; Liver Cirrhosis, Biliary; Male; Prednisolone; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid | 2002 |
Ursodeoxycholic acid for the treatment of cholestatic diseases.
Topics: Adult; Child; Cholangitis, Sclerosing; Cholestasis; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Transplantation; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 1992 |
Liver disease in cystic fibrosis.
Topics: Cystic Fibrosis; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
[New aspects of cystic fibrosis liver disease].
Topics: Adolescent; Cystic Fibrosis; Humans; Liver Diseases; Male; Ursodeoxycholic Acid | 1992 |
[Therapy of cholestatic liver diseases with ursodeoxycholic acid: a new treatment principle].
Topics: Adult; Child; Cholangitis, Sclerosing; Cystic Fibrosis; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Ursodeoxycholic Acid | 1991 |
[Ursodeoxycholic acid. Physical properties and hepatoprotective activity].
Topics: Animals; Bile Acids and Salts; Chemical Phenomena; Chemistry, Physical; Cholestasis; Cystic Fibrosis; Humans; Rats; Ursodeoxycholic Acid | 1991 |
9 trial(s) available for ursodeoxycholic acid and Cystic Fibrosis
Article | Year |
---|---|
The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
Topics: Adolescent; Adult; Child; Cholagogues and Choleretics; Cystic Fibrosis; Disease Progression; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver Diseases; Liver Function Tests; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
Malabsorption of vitamin E in cystic fibrosis improved after ursodeoxycholic acid.
Topics: Adult; Cystic Fibrosis; Gastrointestinal Agents; Humans; Intestinal Absorption; Malabsorption Syndromes; Male; Ursodeoxycholic Acid; Vitamin E | 1995 |
Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial.
Topics: Absorption; Adolescent; Adult; Bile Acids and Salts; Child; Cross-Over Studies; Cystic Fibrosis; Dietary Fats; Female; Humans; Liver Diseases; Male; Nutritional Status; Placebos; Prospective Studies; Taurine; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
Topics: 5'-Nucleotidase; Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Gastrointestinal Agents; Humans; Liver Diseases; Male; Nutritional Status; Prealbumin; Taurine; Ursodeoxycholic Acid | 1996 |
Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Bile Acids and Salts; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Liver Diseases; Male; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis.
Topics: Adolescent; Child; Cholagogues and Choleretics; Cross-Over Studies; Cystic Fibrosis; Double-Blind Method; Fatty Acids, Essential; Female; Humans; Lipid Metabolism; Liver; Liver Function Tests; Male; Ursodeoxycholic Acid; Vitamin A; Vitamins | 1997 |
Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up.
Topics: Adolescent; Adult; Child; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Clinical Enzyme Tests; Cystic Fibrosis; Female; Follow-Up Studies; Humans; Male; Time Factors; Ursodeoxycholic Acid | 1997 |
A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
Topics: Adolescent; Adult; Bile Acids and Salts; Child; Cystic Fibrosis; Female; Gas Chromatography-Mass Spectrometry; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Prospective Studies; Spectrometry, Mass, Fast Atom Bombardment; Treatment Outcome; Ursodeoxycholic Acid | 1998 |
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.
Topics: Bile Acids and Salts; Cystic Fibrosis; Dose-Response Relationship, Drug; Duodenum; Enzymes; Humans; Liver; Liver Diseases; Ursodeoxycholic Acid | 1992 |
36 other study(ies) available for ursodeoxycholic acid and Cystic Fibrosis
Article | Year |
---|---|
Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study.
Topics: Cholagogues and Choleretics; Cohort Studies; Cystic Fibrosis; Humans; Hypertension, Portal; Retrospective Studies; Ursodeoxycholic Acid; Young Adult | 2022 |
Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Cystic Fibrosis; Deoxycholic Acid; Drug Delivery Systems; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Nanomedicine; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Staphylococcus aureus; Ursodeoxycholic Acid | 2018 |
Pancreatic Cystosis and Intrahepatic Biliopathy in a Young Adult with Cystic Fibrosis.
Topics: Abdominal Pain; Adolescent; Biopsy; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Constipation; Contraceptives, Oral; Cystic Fibrosis; Female; Humans; Jaundice; Liver; Liver Diseases; Lung Diseases; Ovarian Cysts; Pancreas; Pancreatic Cyst; Pruritus; Radiography, Abdominal; Tomography, X-Ray Computed; Ursodeoxycholic Acid; Weight Loss | 2018 |
Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
Topics: Adolescent; Child; Cystic Fibrosis; Female; France; Humans; Incidence; Liver Diseases; Male; Retrospective Studies; Risk Factors; Ursodeoxycholic Acid; Young Adult | 2019 |
Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis.
Topics: Analysis of Variance; Body Mass Index; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Liver Cirrhosis; Male; Nutritional Status; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Ultrasonography; Ursodeoxycholic Acid | 2015 |
Supplementation of ursodeoxycholic acid improves fat digestion and absorption in cystic fibrosis patients with mild liver involvement.
Topics: Adolescent; Adult; Breath Tests; Carbon Isotopes; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Dietary Fats; Dietary Supplements; Female; Humans; Liver Diseases; Male; Triglycerides; Ursodeoxycholic Acid; Young Adult | 2016 |
Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
Topics: Adolescent; Adult; Bile Acids and Salts; Biotransformation; Child; Child, Preschool; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Lithocholic Acid; Liver Diseases; Male; Tandem Mass Spectrometry; Ursodeoxycholic Acid; Young Adult | 2016 |
Cystic Fibrosis Liver Disease and Ursodeoxycholic Acid: One Small Step Forward, Miles to Go.
Topics: Bile Acids and Salts; Cystic Fibrosis; Humans; Liver; Liver Diseases; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients.
Topics: Adolescent; Child; Cholagogues and Choleretics; Cystic Fibrosis; Drug Monitoring; Elasticity Imaging Techniques; Female; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Netherlands; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.
Topics: Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant; Italy; Liver Diseases; Male; Morbidity; Retrospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.
Topics: Animals; Bile; Bile Acids and Salts; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study.
Topics: Adolescent; Adult; Case-Control Studies; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Infant; Liver Function Tests; Longitudinal Studies; Male; Retrospective Studies; Ursodeoxycholic Acid; Young Adult | 2012 |
Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
Topics: Adolescent; Bile Acids and Salts; Child; Child, Preschool; Cholic Acid; Cystic Fibrosis; Female; Humans; Infant; Liver Diseases; Male; Predictive Value of Tests; Prognosis; Ursodeoxycholic Acid | 2004 |
A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.
Topics: Adult; Cholagogues and Choleretics; Comorbidity; Cystic Fibrosis; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Platelet Count; Prospective Studies; Splenomegaly; Thrombocytopenia; Ursodeoxycholic Acid | 2008 |
Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis.
Topics: Adolescent; Bile Acids and Salts; Chenodeoxycholic Acid; Child; Child, Preschool; Cholic Acids; Cystic Fibrosis; Deoxycholic Acid; Feces; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Lipid Metabolism; Lipids; Male; Ursodeoxycholic Acid | 1983 |
[Treatment of cholestatic liver diseases with phenobarbital and ursodeoxycholic acid].
Topics: Cholestasis, Intrahepatic; Cystic Fibrosis; Female; Humans; Liver Diseases; Liver Function Tests; Male; Phenobarbital; Pregnancy; Pregnancy Complications; Treatment Outcome; Ursodeoxycholic Acid | 1993 |
Surgical treatment of symptomatic biliary stones in patients with cystic fibrosis.
Topics: Adolescent; Adult; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholecystectomy; Cholecystitis; Cholelithiasis; Cystic Fibrosis; Female; Gallstones; Humans; Male; Ursodeoxycholic Acid | 1995 |
Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.
Topics: Adolescent; Adult; Cause of Death; Child; Cystic Fibrosis; Female; Follow-Up Studies; Heart-Lung Transplantation; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Male; Portacaval Shunt, Surgical; Splenectomy; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 1993 |
The role of hepatobiliary scintigraphy in cystic fibrosis.
Topics: Adolescent; Adult; Biliary Tract; Child; Child, Preschool; Cystic Fibrosis; Female; Follow-Up Studies; Humans; Infant; Liver; Liver Diseases; Male; Prospective Studies; Radionuclide Imaging; Taurine; Ultrasonography; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis.
Topics: Cholagogues and Choleretics; Cholestasis; Cystic Fibrosis; Female; Humans; Infant, Newborn; Liver Function Tests; Male; Treatment Outcome; Ursodeoxycholic Acid | 1997 |
Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease.
Topics: Adolescent; Adult; Bile Ducts; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Intestines; Liver; Liver Diseases; Male; Radionuclide Imaging; Time Factors; Treatment Failure; Ultrasonography; Ursodeoxycholic Acid | 1999 |
Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholagogues and Choleretics; Cystic Fibrosis; Female; Humans; Liver Diseases; Liver Function Tests; Longitudinal Studies; Male; Prospective Studies; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2001 |
Ursodeoxycholic acid ameliorates ibuprofen-induced enteropathy in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catheterization; Cholagogues and Choleretics; Cystic Fibrosis; Disease Models, Animal; Ibuprofen; Intestinal Diseases; Intestines; Lipase; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Serositis; Ulcer; Ursodeoxycholic Acid | 2001 |
Ursodeoxycholic acid action on the transport function of the small intestine in normal and cystic fibrosis mice.
Topics: Animals; Bile Acids and Salts; Biological Transport; Calcium; Cholagogues and Choleretics; Cystic Fibrosis; Dose-Response Relationship, Drug; In Vitro Techniques; Intestinal Mucosa; Intestine, Small; Male; Mast Cells; Membrane Potentials; Mice; Mice, Inbred Strains; Mice, Transgenic; Ursodeoxycholic Acid | 2001 |
Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis.
Topics: 5'-Nucleotidase; Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Bilirubin; Child; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Ursodeoxycholic Acid | 1992 |
Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.
Topics: Adolescent; Bile Ducts; Child; Cystic Fibrosis; Female; Humans; Liver; Liver Diseases; Male; Radionuclide Imaging; Ursodeoxycholic Acid | 1992 |
Liver and biliary problems in cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Animals; Biliary Tract Diseases; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Infant, Newborn; Liver Diseases; Liver Transplantation; Male; Rats; Ursodeoxycholic Acid | 1992 |
[Use of ursodeoxycholic acid in the treatment of hepato-biliary complications in cystic fibrosis].
Topics: Adolescent; Adult; Child; Cholestasis; Cystic Fibrosis; Female; Humans; Liver; Male; Ursodeoxycholic Acid | 1991 |
Cystic fibrosis: another use for urso?
Topics: Adolescent; Adult; Child; Cholestasis; Cystic Fibrosis; Humans; Liver; Nutritional Status; Ursodeoxycholic Acid | 1991 |
Liver dysfunction in cystic fibrosis--beneficial effect of bile acid treatment.
Topics: Bile Acids and Salts; Child; Cholestasis; Cystic Fibrosis; Humans; Liver Function Tests; Taurine; Ursodeoxycholic Acid | 1991 |
Effects of taurine and ursodeoxycholic acid on liver function tests in patients with cystic fibrosis.
Topics: Bile Acids and Salts; Child; Cystic Fibrosis; Female; Humans; Liver Function Tests; Male; Taurine; Ursodeoxycholic Acid | 1990 |
Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.
Topics: Adolescent; Adult; Child; Cholestasis; Chronic Disease; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Liver; Liver Function Tests; Male; Nutritional Status; Prospective Studies; Ursodeoxycholic Acid | 1990 |
Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
Topics: Adolescent; Bile Acids and Salts; Child; Chromatography, High Pressure Liquid; Cystic Fibrosis; Deoxycholic Acid; Female; Gas Chromatography-Mass Spectrometry; Humans; Liver Diseases; Male; Mass Spectrometry; Ursodeoxycholic Acid | 1990 |
Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
Topics: Adolescent; Bile Acids and Salts; Child; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Liver Diseases; Liver Function Tests; Male; Taurine; Ursodeoxycholic Acid | 1990 |
Cholecystectomy as the treatment of choice in cystic fibrosis.
Topics: Cholecystitis; Cystic Fibrosis; Deoxycholic Acid; Humans; Ursodeoxycholic Acid | 1990 |
Ursodeoxycholic acid dissolution of gallstones in cystic fibrosis.
Topics: Adult; Cholecystography; Cholelithiasis; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Male; Ursodeoxycholic Acid | 1988 |